Estradiol
Estradiol is the primary estrogen in menopause HRT, available as patches, gels, sprays, and tablets for hot flashes, sleep, mood, and vaginal symptoms.
How it works
Estradiol levels fall by roughly 90% during the menopause transition, and most common menopause symptoms trace back to that decline: the hypothalamus loses its estrogen signal and begins misfiring temperature regulation (hot flashes, night sweats); brain regions dependent on estrogen become less stable (mood, sleep, cognition); and tissue that requires local estrogen thins or dries out (vaginal and urinary symptoms). Hormone therapy replenishes estradiol to levels that restore signaling across all these systems — which is why symptom improvement tends to appear in phases and across multiple categories simultaneously.
Because estradiol affects so many systems at once, finding the right dose involves more variables than most medications: whether symptoms are adequately controlled, whether side effects like breast tenderness or bloating suggest the dose is higher than needed, and whether the delivery form matches the patient's absorption and risk profile. For people with a uterus, estradiol must be paired with a progestogen to protect the uterine lining. The NAMS 2022 position statement recommends the lowest effective dose for the shortest time appropriate — a target that shifts over time and requires tracking data to navigate accurately.
How to track Estradiol
- Hot flash frequency and severity — the clearest real-time indicator of whether estradiol levels are therapeutically adequate.
- Night sweats separately from daytime hot flashes, since they often track differently and affect sleep independently.
- Sleep quality, including how many nights per week include disruption and whether waking is temperature-related or not.
- Mood stability, irritability, and emotional reactivity — estradiol has direct effects on serotonin and dopamine pathways.
- Vaginal dryness or discomfort — systemic estradiol helps vaginal tissue, though local vaginal estrogen is often added for persistent symptoms.
- Side effects that may signal dose overshoot: breast tenderness, bloating, nausea, or headaches.
- Track across all symptom categories from the start — estradiol affects many systems simultaneously, and improvement rarely arrives uniformly. Sleep might stabilize before hot flashes do, or the reverse.
- Hot flash frequency is the most objective signal of therapeutic adequacy. If frequency hasn't changed meaningfully after four to six weeks at a given dose, that's concrete data for a dose conversation.
- Log side effects like breast tenderness and bloating as carefully as you log symptoms — they're the leading indicator that a dose may be higher than the minimum effective level.
- Record your application or dose times consistently. Even a one-day gap with transdermal forms can cause a symptom breakthrough — your log will show whether breakthrough episodes cluster after missed doses.
- When your physician adjusts dose or formulation, note the exact date so you can compare before-and-after windows clearly. Changes often take two to four weeks to fully show.
Questions to ask your physician
- My hot flash frequency before starting was [baseline]. My current weekly average is [X]. Does that trajectory suggest I'm reaching therapeutic estradiol levels?
- I've been logging breast tenderness since [date] — does the pattern and timing suggest my dose may be higher than the minimum effective level?
- My sleep tracking still shows [X] nights of disruption per week at [Y weeks on therapy]. Is that expected to continue improving, or does it suggest a formulation or dose review?
- My mood and irritability log shows [pattern]. Is that consistent with estradiol at this dose, or could it point to the progesterone component?
- Here is my dose adherence log for the past four weeks — are there any gaps or patterns worth discussing before we evaluate whether this dose is working?